The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.
Kehoe PG, Blair PS, Howden B, Thomas DL, Malone IB, Horwood J, Clement C, Selman LE, Baber H, Lane A, Coulthard E, Passmore AP, Fox NC, Wilkinson IB, Ben-Shlomo Y.
Kehoe PG, et al. Among authors: blair ps.
J Alzheimers Dis. 2018;61(2):803-814. doi: 10.3233/JAD-170101.
J Alzheimers Dis. 2018.
PMID: 29226862